Vancomycin and nephrotoxicity: just another myth? - Wikidata - awgldk - TriplyDB

Vancomycin and nephrotoxicity: just another myth?

Vancomycin and nephrotoxicity: just another myth?

http://www.wikidata.org/entity/Q30409849

about

Review of vancomycin-induced renal toxicity: an update Optimizing the Clinical Use of Vancomycin Top Guns: The "Maverick" and "Goose" of Empiric Therapy.Vancomycin-Associated Nephrotoxicity: The Obesity Factor The Whole Price of Vancomycin: Toxicities, Troughs, and Time Vancomycin and the Risk of AKI: A Systematic Review and Meta-Analysis.Biosafety of the Novel Vancomycin-loaded Bone-like Hydroxyapatite/Poly-amino Acid Bony Scaffold The Nephrotoxicity of Vancomycin Risk of acute kidney injury in critically ill surgical patients with presumed pneumonia is not impacted by choice of methicillin-resistant staphylococcus aureus therapy.Clinical outcomes after initial treatment of methicillin-resistant infections

P2860

Q26746932-6B10B91D-D0E4-4A0B-8E3E-63AD01CC6A77 Q28069334-774271E6-0DF4-42E4-8B44-7A74726A9DAD Q30278491-BFEB285C-C405-4088-A29C-63D23C162498 Q30278775-5DB8513B-A5A5-4DB5-8DE8-AE528CEE7988 Q33885191-40EFD43C-7C1E-432F-B60A-72605211DFE2 Q36206165-CD463D72-8B23-4974-BEB1-3188212C02BA Q36705481-0873B266-11FA-4F78-A1E6-5B2FCEC991DB Q38687487-D6034A7E-97D1-4B78-B6F3-C9502EDC45DE Q53698257-51F70B4B-51ED-4F37-8382-72DBDE8F1F8B Q58799236-84A72BD4-EADF-4A71-B782-83E1A4150DF8

P2860

Vancomycin and nephrotoxicity: just another myth?

http://www.wikidata.org/entity/Q30409849

description

2013 nî lūn-bûn

@nan

2013 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2013 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2013年の論文

@ja

2013年論文

@yue

2013年論文

@zh-hant

2013年論文

@zh-hk

2013年論文

@zh-mo

2013年論文

@zh-tw

2013年论文

@wuu

name

Vancomycin and nephrotoxicity: just another myth?

@ast

Vancomycin and nephrotoxicity: just another myth?

@en

type

label

Vancomycin and nephrotoxicity: just another myth?

@ast

Vancomycin and nephrotoxicity: just another myth?

@en

prefLabel

Vancomycin and nephrotoxicity: just another myth?

@ast

Vancomycin and nephrotoxicity: just another myth?

@en

P1433

Q30409849-B7DCDCD3-2E75-4B18-AC16-E2F77332D02D

P1476

Q30409849-4656D1A3-E477-4C24-B80F-92898E64C206

P2093

Q30409849-5305AD0E-D9B1-4B24-8DAB-9E938354B094

Q30409849-6FCEE438-FD5D-4CDF-B6A7-B6FFF991DE21

Q30409849-7785B918-4E15-49DD-950E-0A20FAFEF5D5

Q30409849-7F01DF2F-05A5-41C0-B382-8CCA4F3A93FD

P2860

Q30409849-08073CF1-5066-48DC-BDDE-E8575B736ADB

Q30409849-1EB9642F-DD51-42EA-849D-360064F91CDA

Q30409849-1FF2DFAD-2ACA-4A0F-A39B-93BF04FBDA8C

Q30409849-225CA22F-8BA9-4A8F-8A66-9524DA160047

Q30409849-22FB3FF7-83A6-4A7E-8668-E75892627EC5

Q30409849-2655BC79-FC65-42F3-B1BB-871AFB8E2145

Q30409849-26FB1302-6E23-4D65-9D9C-5CD56654377E

Q30409849-27706D82-310B-4B9C-BA0E-7283999A15E0

Q30409849-2F1A266C-CA6C-4727-9365-7140DD5C0355

Q30409849-2F62CD7D-D673-49CB-ACA2-9F5B62124E5C

P304

Q30409849-536FF623-72F4-414B-8C11-0D803781F7C9

P31

Q30409849-30B337C6-CEBC-4F55-937C-957AF1FA6433

P356

Q30409849-B7986DCB-02A2-4960-9FBF-13C517CEC404

P433

Q30409849-606338DE-8495-4094-A9ED-C0DBB372E00A

P478

Q30409849-4B704EC8-959A-44AC-B58A-7A3A21B06035

P50

Q30409849-CCA9DF08-94FA-46AB-AA0A-12CDE96AF481

P577

Q30409849-D84D57A4-7A31-44F7-B715-B0B056FCCD1A

P5875

Q30409849-5D614231-8FAD-4D28-9A21-0587FAB8D785

P698

Q30409849-246E1DDC-C060-4FE7-95D5-1C54615903A3

P932

Q30409849-1F89BDDC-2AE7-46DF-95CA-5E10060FDF20

P356

TA.0B013E3182A74B70

P1433

The Journal of Trauma and Acute Care Surgery

P1476

Vancomycin and nephrotoxicity: just another myth?

@en

P2093

Christopher A Guidry

http://www.w3.org/2001/XMLSchema#string

Robin T Petroze

http://www.w3.org/2001/XMLSchema#string

Stephen W Davies

http://www.w3.org/2001/XMLSchema#string

Tjasa Hranjec

http://www.w3.org/2001/XMLSchema#string

P2860

Double-blind comparison of teicoplanin versus vancomycin in febrile neutropenic patients receiving concomitant tobramycin and piperacillin: effect on cyclosporin A-associated nephrotoxicity

Changes in the prevalence of nasal colonization with Staphylococcus aureus in the United States, 2001-2004.

Linezolid versus vancomycin for the treatment of infections caused by methicillin-resistant Staphylococcus aureus in Japan.

Benefit-risk assessment of linezolid for serious gram-positive bacterial infections.

Vancomycin-associated nephrotoxicity: grave concern or death by character assassination?

Effects of teicoplanin and those of vancomycin in initial empirical antibiotic regimen for febrile, neutropenic patients with hematologic malignancies. Gimema Infection Program.

Linezolid versus vancomycin in treatment of complicated skin and soft tissue infections.

Hospitalizations and deaths caused by methicillin-resistant Staphylococcus aureus, United States, 1999-2005

The importance of tissue penetration in achieving successful antimicrobial treatment of nosocomial pneumonia and complicated skin and soft-tissue infections caused by methicillin-resistant Staphylococcus aureus: vancomycin and linezolid.

Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.

P304

830-835

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1097/TA.0B013E3182A74B70

http://www.w3.org/2001/XMLSchema#string

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

75

http://www.w3.org/2001/XMLSchema#string

P50

Robert G. Sawyer

P577

2013-11-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

258043658

http://www.w3.org/2001/XMLSchema#string

P698

24158202

http://www.w3.org/2001/XMLSchema#string

P932

3815465

http://www.w3.org/2001/XMLSchema#string